Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
15.01
-0.24 (-1.57%)
At close: Jan 30, 2026, 4:00 PM EST
15.02
+0.01 (0.07%)
After-hours: Jan 30, 2026, 7:14 PM EST
Eton Pharmaceuticals Market Cap
Eton Pharmaceuticals has a market cap or net worth of $402.53 million as of January 30, 2026. Its market cap has increased by 5.69% in one year.
Market Cap
402.53M
Enterprise Value
396.29M
1-Year Change
5.69%
Ranking
Category
Stock Price
$15.01
Market Cap Chart
Since November 13, 2018, Eton Pharmaceuticals's market cap has increased from $105.74M to $402.53M, an increase of 280.68%. That is a compound annual growth rate of 20.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 402.53M | -11.24% |
| Dec 31, 2025 | 453.48M | 27.82% |
| Dec 31, 2024 | 354.78M | 215.68% |
| Dec 29, 2023 | 112.38M | 57.54% |
| Dec 30, 2022 | 71.34M | -32.42% |
| Dec 31, 2021 | 105.56M | -46.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BGM Group | 645.70M |
| Emergent BioSolutions | 626.04M |
| Kamada | 503.49M |
| Organogenesis Holdings | 496.86M |
| SIGA Technologies | 477.29M |
| Canopy Growth | 431.38M |
| Aquestive Therapeutics | 385.53M |
| Akebia Therapeutics | 379.47M |